Statistics
Publications
12
Citations
427
H-Index
12
Active since
2017
Changcan Li is an author at Shanghai Jiao Tong University specializing in oncology, medicine, and molecular oncology.
Publications per year
2017–2024
12
12
DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity
Ying Xue, Xuebing Jia, Changcan Li et al. · Cell Death and Disease · 2019 · 46 citations · Full text
Medicine, Cancer Biology, Oncology +14
TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer
Mengdi Yang, Qianru Huang, Changcan Li et al. · Frontiers in Immunology · 2021 · 34 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 12